Overview from the 2025 International Stroke Conference - Part 2
In part two of this two-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the PRESTIAGE-AF trial. Show references: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25...
6 Mar 20253min
Overview from the 2025 International Stroke Conference - Part 1
In part one of this two-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss two trials that were looking at the use of endovascular therapy for medium vessel occlusion. Show referenc...
5 Mar 20253min
Acquired Dystonia
Dr. Jeff Ratliff delves into the common causes of acquired dystonia and highlights evidence-based treatment strategies for effective management.
4 Mar 20252min
Orthostatic Tremor
Dr. Jeff Ratliff provides an in-depth look at orthostatic tremor, a rare and often overlooked movement disorder, highlighting its symptoms, challenges, and the importance of early detection. Show refe...
3 Mar 20252min
Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 2
In part two of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss the preclinical data and epidemiological data that led us to the phase three study on exenatide. Show reference: h...
28 Feb 20253min
Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 1
In part one of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss recent clinical trials on exenatide as a disease-modifying therapy for Parkinson disease. Show reference: https://...
27 Feb 20252min
Vascular Risk Factor Burden Among Young Adults with Ischemic Stroke
Dr. BJ Hicks and Dr. Aaron Shoskes discuss the rising incidence of ischemic stroke in young adults. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000213447
26 Feb 20252min
First Drug Approved in New Class of Non-Opioid Pain Medicines
Dr. Tesha Monteith discusses Journavx (suzetrigine), a new medication for pain management. Show references: https://www.fda.gov/news-events/press-announcements/fda-approves-novel-non-opioid-treatment-...
25 Feb 20252min
